menu
Legionella Testing Market Size, Development Data, Growth Analysis & Forecast 2022 to 2027
The global market for legionella testing is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

Legionella Testing Market is projected to grow from USD 296 million in 2022 to USD 439 million by 2027, at a CAGR of 8.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. ,as businesses around the world look to protect their employees, customers and other visitors. Legionella testing is becoming an increasingly important part of many businesses' safety and health protocols. As awareness of Legionella bacteria and the threat it poses to the health of building occupants grows, so does the demand for testing to ensure that Legionella levels in water systems remain low.

In this blog post, we’ll take a look at the current state of the Legionella testing market, the key drivers of its growth and the challenges it faces. We’ll also look at the different types of Legionella tests available, the benefits they offer, and the importance of conducting regular testing.

Download Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173145333

List of Key Players:

The major players operating in this legionella testing market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).

The Legionella testing market is driven by a combination of factors, including the need to meet regulatory requirements, the risk of Legionella-related illnesses, and the increasing awareness of the bacteria's potential health risks. As more countries introduce regulations requiring testing for Legionella, the market for testing services is expected to grow. Additionally, an increasing number of businesses are recognizing the need to protect their employees, customers and other visitors from potential Legionella-related illnesses, and are investing in testing services to do so.

There are several types of Legionella tests available, including culture-based testing, qPCR testing, ELISA testing, and ATP testing. Each type of test has its own benefits and drawbacks, and the most appropriate test will depend on the needs of the particular application. Culture-based testing is often used in situations where a comprehensive picture of the bacteria present in a water system is needed. qPCR testing is more sensitive than culture-based testing and is therefore used when a higher level of accuracy is needed. ELISA testing is used to measure the presence of Legionella-specific antibodies, while ATP testing is used to measure the levels of ATP present in a water system, which can indicate the presence of Legionella.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173145333

Regular testing for Legionella is essential for businesses to ensure the safety of their occupants. Testing can identify the presence of Legionella bacteria before it can cause illness, allowing businesses to take action to reduce the risk of Legionella-related illnesses. It can also help to ensure compliance with local regulations, and provide peace of mind to businesses and their customers.

The global Legionella testing market is expected to continue to grow in the coming years, as businesses around the world increasingly recognize the importance of testing for Legionella. As awareness of the risks posed by Legionella bacteria grows and more countries introduce regulations requiring testing, the demand for testing services is expected to increase. It is essential for businesses to ensure they are conducting regular testing for Legionella to protect their employees, customers and other visitors from potential harm.

This report categorizes the global legionella testing market into the following segments and subsegments:

By Test Type

  • Culture Methods
  • Urinary Antigen Tests
  • Direct Fluorescent Antibody Tests
  • PCR

By Application

  • Water Testing
  • IVD Testing
  • Other Applications

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Water & Other Industries
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In December 2021, IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company’s international reference laboratory presence.
  • LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
  • Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=173145333

 

Related Reports:

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027

 

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

 

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com